Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adalimumab: a new modality for Behçet's disease?

J A M van Laar, T Missotten, P L A van Daele

    Annals of the Rheumatic Diseases
    |November 25, 2006
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Determinants of Total and Inhaled Allergen-Specific Immunoglobulin E in the Middle-Aged and Elderly Population.

    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
    Same author

    Adnexal necrobiotic xanthogranuloma presenting as a "kissing" eyelid lesion.

    Orbit (Amsterdam, Netherlands)·2026
    Same author

    Impact of switching from the originator adalimumab to a biosimilar: a retrospective cohort study.

    BMC immunology·2025
    Same author

    Improving organisation to improve care: ERN ReCONNET organisational reference model for systemic sclerosis patients' care pathway.

    Journal of scleroderma and related disorders·2024
    Same author

    Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study.

    Lancet (London, England)·2024
    Same author

    Histological evidence of MAPK pathway activation across subtypes of adult orbital xanthogranulomatous disease irrespective of the detection of oncogenic mutations.

    Clinical immunology (Orlando, Fla.)·2024